MyFinsight
Home
About
Contact
Back
Income Statement
Ultragenyx Pharmaceutical Inc. (RARE)
source: myfinsight.com
Download
Download image
Net loss
-$114,951K
Crysvita
$34,727K
Dojolvi
$23,207K
Evkeeza
$14,573K
Mepsevii
$8,310K
Loss before income
taxes
-$114,004K
Provision for income taxes
$947K
Interest income
$5,794K
Other income
(expense)
$2,140K
Revenue from contract
with customer,...
$85,679K
Revenue from contract
with customer,...
$80,817K
Non-cash interest
expense on liabilities...
$14,041K
Change in fair value of
equity investments
-$9K
Loss from operations
-$107,888K
Total revenues
$166,496K
Total operating
expenses
$274,384K
Cost of sales
$23,002K
Research and development
$164,736K
Selling, general and
administrative
$86,646K
Back